Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
💰 Warren Buffett reveals a $6.72 billion stake in ChubbCopy Portfolios

United Therapeutics: Vol Elevates To Annual Highs; Earnings Risk Rises

ByOphir Gottlieb
Published 10/12/2012, 05:03 AM
Updated 07/09/2023, 06:31 AM
PMCN
-
NOTE
-
UTHR
-

United Therapeutics Corporation (UTHR) is a biotechnology company focused on the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening conditions.

This is a vol note -- while earnings are approaching we expect to see vol rise, but this one really caught my eye. Let's start with the Charts Tab (six months), below. The top portion is the stock price, the bottom is the vol (IV30™ - red vs HV20™ - blue vs HV180™ - pink).

UTHR_CHART
On the stock side we can see an impressive rise over the last six months from the low $40's to now over $56 and on a rather steady trajectory.

On the vol side, we see the story. The implied has been rising exponentially as earnings approach (end of Oct / early Nov). The level is easily a six-month high and is on the brink of becoming an annual high. The 52 wk range in IV30™ is [27.38%, 56.64%], putting the current level in the 99th percentile. The last time the implied hit this level was the earnings release a few quarters ago.

Let's turn to the Skew Tab.

UTHR_SKEW
We can see a normal skew shape across all three front expiries, with Nov elevated to the other two b/c of he earnings release.

Finally, let's turn to the Options Tab.

UTHR_OPTIONS
Across the top we can see the monthly vols are priced to 36.21% for Oct and 62.25% for Nov. Given that there are still a few more weeks to go before earnings, it's apparent to me that IV30™ will hit an annual high before this event. This is one of a handful of companies I've noted recently where the implied will be breaching annual highs into earnings. Hey, it's October in finance -- risk is here.

Disclosure: This is trade analysis, not a recommendation.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.